摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(甲氧基羰基)-2-甲基苯硼酸 | 158429-38-0

中文名称
4-(甲氧基羰基)-2-甲基苯硼酸
中文别名
——
英文名称
(4-(methoxycarbonyl)-2-methylphenyl)boronic acid
英文别名
(4-methoxycarbonyl-2-methylphenyl)boronic acid
4-(甲氧基羰基)-2-甲基苯硼酸化学式
CAS
158429-38-0
化学式
C9H11BO4
mdl
MFCD16036117
分子量
193.995
InChiKey
MOBGLFACQCDFEQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    366.7±52.0 °C(Predicted)
  • 密度:
    1.21±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.25
  • 重原子数:
    14
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.222
  • 拓扑面积:
    66.8
  • 氢给体数:
    2
  • 氢受体数:
    4

安全信息

  • 危险性防范说明:
    P261,P305+P351+P338
  • 危险性描述:
    H315,H319,H335

SDS

SDS:ef5329a34e2d280bec90caba0ca5dcab
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 4-(Methoxycarbonyl)-2-methylphenylboronic acid
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 4-(Methoxycarbonyl)-2-methylphenylboronic acid
CAS number: 158429-38-0

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C9H11BO4
Molecular weight: 194.0

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    4-(甲氧基羰基)-2-甲基苯硼酸N-溴代丁二酰亚胺(NBS)偶氮二异丁腈 作用下, 以 四氯化碳甲苯 为溶剂, 反应 36.0h, 生成 3-Bromomethyl-4-(5,5-dimethyl-[1,3,2]dioxaborinan-2-yl)-benzoic acid methyl ester
    参考文献:
    名称:
    模块化固相合成方法可优化寡硼酸受体和传感器的结构和电子性能,以进行寡糖的水相识别。
    摘要:
    本文介绍了第一种完全模块化,平行固相合成方法的设计和优化,该方法用于生成定义明确的多胺寡硼酸受体和复杂寡糖的荧光传感器。合成方法允许有效构建受体多胺主链,然后控制胺苄基侧链的多样化。这种方法能够以模块化的方式测试被无阻碍的对位吸电子基团或供电子基团取代的不同芳基硼酸单元的作用。还通过使用Irori MiniKan技术组装受体子库,研究了这种自动合成方法的可行性。合成了包含两个或三个芳基硼酸的蒽封端的传感器的几个子库,并在中性水性介质中检查了它们与一系列模型二糖的结合。通过荧光滴定法对缔合常数的计算证实,聚胺主链中胺间间隔基结构的细微变化可对所得配合物的稳定性产生重大影响。最重要的是,这项研究导致确定了芳基硼酸酯单元的首选电子特性,并暗示了新一代的含有非常贫电子的芳基硼酸的受体可能会导致结合亲和力的显着改善。通过荧光滴定法对缔合常数的计算证实,聚胺主链中胺间间隔基结构的细微变化可对所得配合物
    DOI:
    10.1002/chem.200305400
  • 作为产物:
    描述:
    3-甲基-4-溴苯甲酸盐酸正丁基锂硫酸 作用下, 以 乙醚正己烷 为溶剂, 反应 22.5h, 生成 4-(甲氧基羰基)-2-甲基苯硼酸
    参考文献:
    名称:
    模块化固相合成方法可优化寡硼酸受体和传感器的结构和电子性能,以进行寡糖的水相识别。
    摘要:
    本文介绍了第一种完全模块化,平行固相合成方法的设计和优化,该方法用于生成定义明确的多胺寡硼酸受体和复杂寡糖的荧光传感器。合成方法允许有效构建受体多胺主链,然后控制胺苄基侧链的多样化。这种方法能够以模块化的方式测试被无阻碍的对位吸电子基团或供电子基团取代的不同芳基硼酸单元的作用。还通过使用Irori MiniKan技术组装受体子库,研究了这种自动合成方法的可行性。合成了包含两个或三个芳基硼酸的蒽封端的传感器的几个子库,并在中性水性介质中检查了它们与一系列模型二糖的结合。通过荧光滴定法对缔合常数的计算证实,聚胺主链中胺间间隔基结构的细微变化可对所得配合物的稳定性产生重大影响。最重要的是,这项研究导致确定了芳基硼酸酯单元的首选电子特性,并暗示了新一代的含有非常贫电子的芳基硼酸的受体可能会导致结合亲和力的显着改善。通过荧光滴定法对缔合常数的计算证实,聚胺主链中胺间间隔基结构的细微变化可对所得配合物
    DOI:
    10.1002/chem.200305400
点击查看最新优质反应信息

文献信息

  • Scope of regioselective Suzuki reactions in the synthesis of arylpyridines and benzylpyridines and subsequent intramolecular cyclizations to azafluorenes and azafluorenones
    作者:Joydev K. Laha、Ketul V. Patel、Saima Saima、Surabhi Pandey、Ganesh Solanke、Vanya Vashisht
    DOI:10.1039/c8nj02734j
    日期:——
    current investigation on regioselective Suzuki reactions of 2,3-dihalopyridines and 2-halo-3-halomethylpyridines yielded the unexplored synthesis of arylpyridines and benzylpyridines bearing synthetic handles for further functionalization. Indeed, the scope of intramolecular cyclizations of arylpyridines and benzylpyridines prepared in this study for the synthesis of azafluorenes and azafluorenones has been
    目前对2,3-二卤代吡啶和2-卤代-3-卤代甲基吡啶的区域选择性Suzuki反应的研究产生了未经探索的芳基吡啶和苄基吡啶的合成,其带有用于进一步官能化的合成手柄。实际上,已经研究了在这项研究中制备的用于合成氮杂芴和氮杂芴酮的芳基吡啶和苄基吡啶的分子内环化的范围。
  • Aminoalcohol derivatives
    申请人:FUJISAWA PHARMACEUTICAL CO., LTD.
    公开号:US20040006143A1
    公开(公告)日:2004-01-08
    The present invention relates to a compound formula [I]: 1 wherein 2 Y is bond, —O—(CH 2 ) n — (in which n is 1, 2, 3 or 4), etc., Z is cyano, tetrazolyl, etc., R 1 is hydrogen, lower alkyl, etc., R 2 is hydrogen or an amino protective group, R 3 is hydrogen or lower alkyl, R 4 is hydrogen or lower alkyl, R 5 and R 8 are each independently hydrogen, halogen, hydroxy, lower alkyl, etc., R 6 is hydrogen, lower alkyl, etc., R 9 is hydrogen or lower alkyl, and i is 1 or 2, or a salt thereof. The compound [I] of the present invention and pharmaceutically acceptable salts thereof are useful for the prophylactic and/or the therapeutic treatment of pollakiurea or urinary incontinence.
    本发明涉及一种化合物公式[I]: 1 其中 2 Y是键,—O—(CH 2 ) n — (其中n是1、2、3或4),等等, Z是氰基,四唑基,等等, R 1 是氢,低级烷基,等等, R 2 是氢或氨基保护基团, R 3 是氢或低级烷基, R 4 是氢或低级烷基, R 5 和R 8 各自独立是氢,卤素,羟基,低级烷基,等等, R 6 是氢,低级烷基,等等, R 9 是氢或低级烷基,以及 i是1或2, 或其盐。本发明的化合物[I]及其药用可接受的盐对于预防性和/或治疗性治疗尿频或尿失禁是有用的。
  • INDOLE DERIVATIVES AS CRAC MODULATORS
    申请人:Alam Muzaffar
    公开号:US20110071150A1
    公开(公告)日:2011-03-24
    Compounds of the formula I: or pharmaceutically acceptable salts thereof, wherein R 1 , R 2 , R 3 and R 4 are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of diseases associated with calcium release-activated calcium channels (CRAC).
    公式I的化合物: 或其药用可接受的盐, 其中R1、R2、R3和R4按本文定义。还公开了制造这些化合物的方法以及使用这些化合物治疗与钙释放激活钙通道(CRAC)相关疾病的用途。
  • Chemoselective Borono-Catellani Arylation for Unsymmetrical Biaryls Synthesis
    作者:Peng Wang、Shuqing Chen、Zhiyu Zhou、Hong-Gang Cheng、Qianghui Zhou
    DOI:10.1021/acs.orglett.9b01072
    日期:2019.5.3
    Reported is the borono-Catellani arylation process for unsymmetrical biaryls synthesis, utilizing the readily available pinacol ester of arylboronic acids, aryl bromides, and olefins as the reactants. The distinct reactivity of arylboronic ester and aryl bromides secures the excellent chemoselectivity in the pivotal arylation step. The reaction is enabled by the cooperative catalysis of Pd(OAc)2 and
    报告了不对称联芳基合成的硼碳-卡泰拉尼芳基化方法,该方法利用易得的芳基硼酸,芳基溴化物和烯烃的频哪醇酯作为反应物。芳基硼酸酯和芳基溴化物的独特反应性可确保关键的芳基化步骤具有出色的化学选择性。通过以分子氧作为末端氧化剂的Pd(OAc)2和NBE衍生物N 7的协同催化使反应得以实现。
  • Redox-Neutral ortho Functionalization of Aryl Boroxines via Palladium/Norbornene Cooperative Catalysis
    作者:Renhe Li、Feipeng Liu、Guangbin Dong
    DOI:10.1016/j.chempr.2019.02.005
    日期:2019.4
    cooperative catalysis, also known as the Catellani reaction, has become an increasingly useful method for site-selective arene functionalization; however, certain constraints still exist because of its intrinsic mechanistic pathway. Herein, we report a redox-neutral ortho functionalization of aryl boroxines via Pd/NBE catalysis. An electrophile, such as carboxylic acid anhydrides or O-benzoyl hydroxylamines,
    钯/降冰片烯(Pd / NBE)协同催化,也称为Catellani反应,已成为位点选择性芳烃官能化的一种越来越有用的方法。但是,由于其固有的机理途径,仍然存在某些限制。在这里,我们报告通过Pd / NBE催化的芳基硼氧烷的氧化还原中性邻位官能化。亲电子试剂,例如羧酸酐或O-苯甲酰基羟胺,在环硼氧烷邻位偶联,质子作为第二种亲电子试剂引入ipso位置。该反应不需要额外的氧化剂或还原剂,并且避免了化学计量的碱或酸,从而可以耐受各种官能团。特别地,证明了芳基碘和环硼氧烷部分之间的正交化学选择性,其可用于控制反应序列。最后,氘标记研究支持ipso质子化途径。这种独特的机械特性可能会激发新型Pd / NBE催化的转化的发展。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐